The immune TME, with special reference to T lymphocytes and the CD8+ cytotoxic subpopulation, is increasingly acquiring relevance in the field of oncology, as understanding the interplay between immune system and cancer is critical to adequately exploit immunotherapy. This evidence concerns the gene CD8A and cancer.